{"result": "(\"entity\"<|>HIPOALDOSTERONISMO<|>EVENT<|>Hypoaldosteronism is a condition that can lead to alterations in electrolyte balance and may contribute to bone health issues, including osteoporosis.)\n##\n(\"entity\"<|>HIPERTIROIDISMO<|>EVENT<|>Hyperthyroidism is a condition that can lead to increased bone resorption and is a risk factor for osteoporosis.)\n##\n(\"entity\"<|>ENFERMEDADES MALABSORTIVAS<|>EVENT<|>Malabsorption diseases can affect nutrient absorption, leading to deficiencies that may contribute to osteoporosis.)\n##\n(\"entity\"<|>ENFERMEDADES RENALES<|>EVENT<|>Renal diseases can impact bone health and are associated with an increased risk of osteoporosis.)\n##\n(\"entity\"<|>ENFERMEDADES HEMATOLÓGICAS<|>EVENT<|>Hematological diseases can influence bone density and contribute to the risk of osteoporosis.)\n##\n(\"entity\"<|>ENFERMEDADES INFLAMATORIAS CRÓNICAS<|>EVENT<|>Chronic inflammatory diseases can affect bone metabolism and increase the risk of osteoporosis.)\n##\n(\"relationship\"<|>HIPERTIROIDISMO<|>OSTEOPOROSIS<|>Hyperthyroidism is a condition that can lead to increased bone resorption, contributing to osteoporosis<|>6)\n##\n(\"relationship\"<|>HIPOALDOSTERONISMO<|>OSTEOPOROSIS<|>Hypoaldosteronism can lead to electrolyte imbalances that may affect bone health and contribute to osteoporosis<|>5)\n##\n(\"relationship\"<|>ENFERMEDADES MALABSORTIVAS<|>OSTEOPOROSIS<|>Malabsorption diseases can lead to nutrient deficiencies that increase the risk of osteoporosis<|>6)\n##\n(\"relationship\"<|>ENFERMEDADES RENALES<|>OSTEOPOROSIS<|>Renal diseases can negatively impact bone health and increase the risk of osteoporosis<|>6)\n##\n(\"relationship\"<|>ENFERMEDADES HEMATOLÓGICAS<|>OSTEOPOROSIS<|>Hematological diseases can affect bone density and contribute to osteoporosis<|>5)\n##\n(\"relationship\"<|>ENFERMEDADES INFLAMATORIAS CRÓNICAS<|>OSTEOPOROSIS<|>Chronic inflammatory diseases can lead to changes in bone metabolism, increasing the risk of osteoporosis<|>6)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: im-                         varones. Debido a que la DMO disminuye con la edad,\nportante, ya que la severidad de la hipomagnesemia se                         la incidencia de fracturas aumenta exponencialmente\ncorrelaciona con la magnitud de la grasa fecal. En pérdi-                     en ambos sexos, siendo un problema alarmante en la\ndas cutáneas, destacarían los quemados severos y de-                          población senil, un sector demográfico con clara ten-\nportistas tras un ejercicio extenuante con fases anabóli-                     dencia ascendente. Entre los factores de riesgo impli-\ncas. Existen numerosas alteraciones hormonales que                            cados en la disminución de la masa ósea y el aumento\nproducen hipermagnesiuria como son el hipoparatiroi-                          de la fragilidad se encuentran:\ndismo, la diabetes (diuresis osmótica), el hipertiroidis-\nmo, el aumento de la hormona antidiurética y los mine-                           •  Fracaso en obtener un pico óptimo de masa ósea\nralocorticoides (por la hipervolemia y por el déficit de                            (en el individuo sano se alcanza a los 30-35 años).\npotasio). También existen tubulopatías que cursan con                            •  Elevación de la resorción y disminución de la for-\nhipermagnesiuria como los síndromes de Welt, Bartter o                              mación ósea (con la edad, predomina la resorción\nGitelman. En cuanto a las nefropatías funcionales que                               frente a la formación).\ncausan hipermagnesiuria, en la mayoría de los casos                              •  Cambios hormonales (disminución de estrógenos y\nestán ocasionadas por factores nutricionales como el                                andrógenos, aumento de PTH y disminución de vi-\nayuno, deficiencias de fósforo, potasio, vitamina B6, vi-                           tamina D, disminución de GH e IGF-1 con la edad).\ntamina E, así como el exceso de proteína en la dieta.\nNumerosos fármacos pueden favorecer la hipermagne-                               Existen otros factores que pueden favorecer la apari-\nsiuria como los diuréticos de asa, tiazidas o manitol, el                     ción de osteoporosis, los más frecuentes serían:\ncisplatino o la anfotericina B. Destacan también fárma-\ncos relativamente nuevos como los anticuerpos mono-                              •  Estilo de vida: Baja ingesta de calcio y niveles bajos\nclonales bloqueantes del receptor del factor de creci-                              de vitamina D. Sedentarismo, tabaquismo, consu-\nmiento epidérmico (cetuximab y panitumumab)2, 7.                                    mo de alcohol, bajo índice de masa muscular, die-\n   Clínicamente, la hipomagnesemia se manifiesta por                                tas desequilibradas.\nanorexia, espasmo muscular, temblor, astenia, convul-                            •  Fármacos: Glucocorticoides, antiandrógenos, ex-\nsión, irritabilidad muscular, agitación, confusión, alte-                           ceso de dosis de tiroxina, anticonvulsivantes.\nraciones digestivas, disminución de las reservas de                              •  Endocrinopatías: Hipertiroidismo, diabetes mellitus,\nglucógeno hepático y muscular y alteraciones en el                                  enfermedad de Cushing, hipogonadismos, hiperpa-\nmetabolismos del calcio aumentando su depósito en                                   ratiroidismo.\ntejidos blandos como el miocardio, el riñón o las pare-                          •  Enfermedades malabsortivas, enfermedades rena-\ndes vasculares.7                                                                    les, hematológicas e inflamatorias crónicas.\n\n\n\n5.   Osteoporosis                                                                La osteoporosis es una enfermedad asintomática\n                                                                              que se manifiesta con la aparición de fracturas espon-\n   La osteoporosis ha sido definida como una enfer-                           táneas o ante traumatismos mínimos. Estas fracturas\nmedad caracterizada por una masa ósea disminuida                              pueden recuperarse completamente o dejar secuelas a\nacompañada de un deterioro de la microarquitectura                            largo plazo que pueden manifestarse como dolor cró-\ndel tejido óseo, lo que conduce a un aumento de su                            nico o con deformidades que pueden tener como con-\nfragilidad y por consiguiente, a un incremento del ries-                      secuencia insuficiencia respiratoria restrictiva, encama-\ngo de fractura. En 1994 la Organización Mundial de la                         miento o incluso la muerte; esta última relacionada\nSalud (OMS) recomendó una definición clínica basada                           sobre todo con la fractura de cadera.\nen mediciones de la densidad mineral ósea (DMO) ex-                              La prueba o patrón oro para el diagnóstico de la os-\npres\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>ORGANIZACIÓN MUNDIAL DE LA SALUD<|>ORGANIZATION<|>The World Health Organization (WHO) is a specialized agency of the United Nations responsible for international public health, which recommended a clinical definition of osteoporosis in 1994 based on bone mineral density measurements.)\n##\n(\"entity\"<|>OSTEOPOROSIS<|>EVENT<|>Osteoporosis is a disease characterized by decreased bone mass and deterioration of bone microarchitecture, leading to increased fragility and risk of fractures.)\n##\n(\"entity\"<|>DIABETES<|>EVENT<|>Diabetes is a chronic disease that can lead to various complications, including those affecting bone health, such as osteoporosis.)\n##\n(\"entity\"<|>HORMONAL ALTERATIONS<|>EVENT<|>Hormonal alterations can lead to conditions such as osteoporosis by affecting bone density and strength.)\n##\n(\"entity\"<|>FRACTURES<|>EVENT<|>Fractures are breaks in bones that can occur due to osteoporosis, often with minimal trauma.)\n##\n(\"entity\"<|>AGE<|>EVENT<|>Age is a significant factor in the development of osteoporosis, as the risk increases with advancing age.)\n##\n(\"relationship\"<|>ORGANIZACIÓN MUNDIAL DE LA SALUD<|>OSTEOPOROSIS<|>The World Health Organization has defined osteoporosis and recommended guidelines for its diagnosis and management<|>8)\n##\n(\"relationship\"<|>OSTEOPOROSIS<|>FRACTURES<|>Osteoporosis increases the risk of fractures, particularly in older adults<|>9)\n##\n(\"relationship\"<|>OSTEOPOROSIS<|>AGE<|>The risk of developing osteoporosis increases with age<|>7)\n##\n(\"relationship\"<|>DIABETES<|>OSTEOPOROSIS<|>Diabetes is a risk factor that can contribute to the development of osteoporosis<|>6)\n##\n(\"relationship\"<|>HORMONAL ALTERATIONS<|>OSTEOPOROSIS<|>Hormonal alterations are implicated in the development of osteoporosis<|>7)\n<|COMPLETE|>"}]}